Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Sameer Farouk Sait"'
Autor:
Rebecca M. Brown, Sameer Farouk Sait, Griffin Dunn, Alanna Sullivan, Benjamin Bruckert, Daochun Sun
Publikováno v:
Brain Sciences, Vol 12, Iss 6, p 720 (2022)
Neurofibromatosis Type 1 (NF1) is one of the most common genetic tumor predisposition syndromes, affecting up to 1 in 2500 individuals. Up to half of patients with NF1 develop benign nerve sheath tumors called plexiform neurofibromas (PNs), character
Externí odkaz:
https://doaj.org/article/c426eb04c4084341894d1a29877984fd
Publikováno v:
Journal of Human Reproductive Sciences, Vol 4, Iss 2, Pp 70-75 (2011)
Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic complication of assisted reproduction technology. The syndrome is characterized by cystic enlargement of the ovaries and a fluid shift from the intravascular to the third space due to increase
Externí odkaz:
https://doaj.org/article/90c86a4da8fb44abb552ae6c8ed00084
Autor:
Pratap Kumar, Sameer Farouk Sait
Publikováno v:
Journal of Human Reproductive Sciences, Vol 4, Iss 1, Pp 2-7 (2011)
Concept of a ′therapeutic window′ of luteinizing hormone (LH) for successful conception in assisted reproductive technology and ovulation induction has been reviewed in this literature. The separate but complementary roles of follicle stimulating
Externí odkaz:
https://doaj.org/article/f2bedd67b14b4e838934c32dd7ebac1b
Autor:
Sameer Farouk Sait, Alexandra M. Giantini-Larsen, Kathryn R. Tringale, Mark M. Souweidane, Matthias A. Karajannis
Publikováno v:
Current Neurology and Neuroscience Reports. 23:185-199
Autor:
Sameer Farouk Sait, Cheryl Fischer, Zoltan Antal, Krisoula Spatz, Daniel E. Prince, Katarzyna Ibanez, Gerald G. Behr, Ira J. Dunkel, Matthias A. Karajannis
Publikováno v:
Pediatric Blood & Cancer.
Autor:
Tom Rosenberg, Kee Kiat Yeo, Audrey Mauguen, Sanda Alexandrescu, Sanjay P Prabhu, Jessica W Tsai, Seth Malinowski, Mrinal Joshirao, Karishma Parikh, Sameer Farouk Sait, Marc K Rosenblum, Jamal K Benhamida, George Michaiel, Hung N Tran, Sonika Dahiya, Kara Kachurak, Gregory K Friedman, Julie I Krystal, Michael A Huang, Ashley S Margol, Karen D Wright, Dolly Aguilera, Tobey J MacDonald, Susan N Chi, Matthias A Karajannis
Publikováno v:
Neuro Oncol
Background The prognosis for patients with pediatric high-grade glioma (pHGG) is poor despite aggressive multimodal therapy. Objective responses to targeted therapy with BRAF inhibitors have been reported in some patients with recurrent BRAF-mutant p
Publikováno v:
Current opinion in pediatrics.
The fields of precision medicine and cancer genomics in pediatric oncology are rapidly evolving. Novel diagnostic tools are critical in refining cancer diagnoses, stratifying patient risk, and informing treatment decisions. This review is timely and
Autor:
Sameer Farouk Sait, Kwan-ho Tang, Steve Angus, Rebecca Brown, Daochun Sun, Xuanhua Xie, Charlene Iltis, Michelle Lien, Nicholas Socci, Tejus Bale, Christopher Davis, Shelley A.H Dixon, Chi Zhang, D. Wade Clapp, Benjamin G. Neel, Luis F. Parada
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas and the primary cause of mortality in patients with neurofibromatosis type 1 (NF1). MPNSTs develop within pre-existing benign plexiform neurofibromas (PNs). PNs are driven sole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d260dc88d1b4fe6a3ebf56f36e7e57c
https://doi.org/10.1101/2022.08.18.504317
https://doi.org/10.1101/2022.08.18.504317
Autor:
Sameer Farouk Sait, Mauricio Rendon Bernot, Elizabeth Klein, David H. Abramson, Jasmine H. Francis, Stephen Gilheeney, Matthias A. Karajannis, Barbara Spitzer, Suzanne Wolden, Ira J. Dunkel, Nancy A. Kernan
Publikováno v:
Pediatric Blood & Cancer. 70
Stage 4a metastatic retinoblastoma (RB) is curable with intensive multimodality therapy including myeloablative chemotherapy with autologous stem cell transplant (HDC-ASCT) and involved field radiation therapy (IFRT). To our knowledge, no data exist
Autor:
Marina Kushnirsky, Sunitha Thakur, Matthias Karajannis, Tejus Bale, Marc Rosenblum, Rachna Malani, Igor T Gavrilovic, Lauren Schaff, Elena Pentsova, Christian Grommes, Nelson Moss, Sameer Farouk Sait, Katherine Hill, Alexandra Miller, Ingo Mellinghoff, Robert Young, Andrew Lin
Publikováno v:
Neuro-Oncology. 24:vii176-vii177
INTRODUCTION Treatment of brainstem tumors is often initiated without a tissue diagnosis due to the risk of biopsy. A subset of brainstem gliomas harbor an isocitrate dehydrogenase 1/2 (IDH) mutation, which predicts response to alkylator chemotherapy